selfdecode.comCrawled Nov 2, 2026
The page states that DNA tests often provide risk percentiles without actionable advice, while useful supplement recommendations require combining genetic, lab, absorption, and metabolism data.
The page argues that no chatbot can predict how a statin will affect an individual without access to their genome and lab results, highlighting the need for personalized AI genetic analysis.
The page notes that people seek DNA health reports for specific concerns like heart health, blood sugar, or drug reactions, and the right test addresses those in depth.
Heart health is influenced by genetics, but genetic risk does not guarantee disease development.
SelfDecode helps people use DNA and lab tests to improve health, addressing outdated and costly healthcare.
SelfDecode builds a team of innovative professionals to advance personalized healthcare using AI, genetics, and environment.
SelfDecode family plans support up to three users with DNA reports, lab tracking, and personalized recommendations.
SelfDecode offers personalized health insights, diet, supplement, and lifestyle recommendations.
MTHFR gene mutation tests cost between $65 and $800, with varying insurance coverage and pricing factors.
SelfDecode membership provides ongoing DNA analysis, expert consultations, and member-only features.
SelfDecode assesses genetic risks and provides tailored diet, supplement, and lifestyle recommendations using a full health platform and DNA reports.
SelfDecode combines DNA health reports, an AI health coach, and dynamic recommendations based on lab results, offering a personalized health plan with ongoing support.
SelfDecode provides practitioners with genetic and health data insights to guide patients.
The quality of a genetics product depends on the expertise of its developers and the validation of polygenic models.
SelfDecode employs over 60 professionals in science and engineering.
SelfDecode offers a validated polygenic risk score, whole-genome sequencing, and multi-omics data analysis for personalized health.
Find a trusted precision health practitioner or join as a practitioner to grow your practice.
SelfDecode Pro offers precision health training for practitioners, backed by DNA and lab analysis.
SelfDecode helps practitioners use precision health to treat patients and analyze lab data efficiently.
SelfDecode identifies genetic predispositions and offers personalized health insights, diet, supplement, and lifestyle recommendations based on DNA.
SelfDecode uses HIPAA-grade security and encryption, and does not sell genetic data.
DNA privacy differs from data privacy; SelfDecode’s policies determine whether genetic data is sold or shared.
SelfDecode and PromicsEdge provide informational and educational genetic insights, not medical treatment or diagnosis.
GitHubRepository owner
SelfDecode integrates its AI-driven genetic analysis into MyHeritage’s DNA Traits feature, expanding precision health insights for over 8 million DNA customers. MyHeritage, a global consumer DNA and family history platform, leverages SelfDecode’s technology to enhance user experiences. The partnership extends genetic trait interpretation to a broader audience of registered users.
Jan 2026Yahoo Finance (PR Newswire syndication)News article
MyHeritage launches **DNA Traits**, a new feature analyzing genetic links to traits like taste preferences, sleep patterns, personality, fitness, and cognition. The tool delivers **40 personalized reports** based on scientific research, helping users explore how genetics shape individual differences. This expansion aligns with MyHeritage’s broader push into DNA-based insights for consumers.
Dec 2025MyHeritage BlogNews article
SelfDecode launches **DecodyGPT**, a precision health-focused generative AI tool tailored for personalized health and wellness recommendations. The platform integrates advanced AI to analyze individual health data and provide customized insights. SelfDecode specializes in evidence-based health solutions for users seeking data-driven wellness guidance.
Jul 2024Practical Patient CareNews article
